VACCINEX Trademark

Trademark Overview

On Wednesday, September 10, 2003, a trademark application was filed for VACCINEX with the United States Patent and Trademark Office. The USPTO has given the VACCINEX trademark a serial number of 78298560. The federal status of this trademark filing is REGISTERED AND RENEWED as of Monday, December 8, 2014. This trademark is owned by Vaccinex, Inc.. The VACCINEX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific antibody discovery research, namely, identifying antibodies for use in developing therapeutic antibody products
vaccinex

General Information

Serial Number78298560
Word MarkVACCINEX
Filing DateWednesday, September 10, 2003
Status800 - REGISTERED AND RENEWED
Status DateMonday, December 8, 2014
Registration Number2906537
Registration DateTuesday, November 30, 2004
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 7, 2004

Trademark Statements

Goods and ServicesMedical and scientific antibody discovery research, namely, identifying antibodies for use in developing therapeutic antibody products

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 26, 2003
Primary Code042
First Use Anywhere DateSunday, June 24, 2001
First Use In Commerce DateTuesday, October 29, 2002

Trademark Owner History

Party NameVaccinex, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRochester, NY 14620
Party NameVaccinex, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRochester, NY 14620
Party NameVaccinex, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRochester, NY 14620

Trademark Events

Event DateEvent Description
Thursday, November 30, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, January 19, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, January 19, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 19, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, January 19, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 19, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 19, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, September 6, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 6, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 5, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 5, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 4, 2018WITHDRAWAL OF ATTORNEY GRANTED
Monday, June 4, 2018TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Monday, May 15, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 15, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, December 8, 2014NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Monday, December 8, 2014REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Monday, December 8, 2014REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, December 3, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, November 13, 2014TEAS SECTION 8 & 9 RECEIVED
Tuesday, January 26, 2010REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, January 25, 2010CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, January 16, 2010TEAS SECTION 8 & 15 RECEIVED
Tuesday, November 30, 2004REGISTERED-PRINCIPAL REGISTER
Tuesday, September 7, 2004PUBLISHED FOR OPPOSITION
Wednesday, August 18, 2004NOTICE OF PUBLICATION
Tuesday, June 22, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 14, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 14, 2004PAPER RECEIVED
Wednesday, March 31, 2004NON-FINAL ACTION E-MAILED
Tuesday, March 30, 2004ASSIGNED TO EXAMINER

Related Keywords

vaccinex antibody antibodies developing therapeutic identifying products namely scientific discovery research